Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.22), $0.04 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $10.97 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.